Sofinnova Investments, Inc. Q3 2020 Filing
Filed November 13, 2020
Portfolio Value
$1.3T
Holdings
68
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (68 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera | 3,100,560 | $224.0B | 16.61% | |
| 2 | ASNDAscendis Pharma A/S | 1,109,874 | $171.3B | 12.70% | |
| 3 | KRTXKaruna Therapeutics, Inc. | 1,952,441 | $151.0B | 11.19% | |
| 4 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $84.2B | 6.25% | |
| 5 | INZYInozyme Pharma, Inc. | 2,028,308 | $53.3B | 3.95% | |
| 6 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $41.5B | 3.08% | |
| 7 | AMGNAmgen Inc | 59,500 | $41.2B | 3.06% | Call |
| 8 | —Akouos, Inc | 1,515,073 | $34.6B | 2.57% | |
| 9 | UTHUnited Therapeutics Corp | 320,959 | $32.4B | 2.40% | |
| 10 | ABBVAbbvie Inc | 341,340 | $29.9B | 2.22% | |
| 11 | —Nucana Biomed Ltd | 5,599,999 | $29.0B | 2.15% | |
| 12 | AMGNAmgen Inc | 111,619 | $28.4B | 2.10% | |
| 13 | GRTXGalera Therapeutics, Inc | 3,083,712 | $27.9B | 2.07% | |
| 14 | NXTCNextcure, Inc | 2,671,856 | $23.5B | 1.74% | |
| 15 | LLYLilly Eli & Co | 142,432 | $21.1B | 1.56% | |
| 16 | IM8NInsmed Inc | 615,143 | $19.8B | 1.47% | |
| 17 | BMRNBiomarin Pharmaceutical Inc | 258,653 | $19.7B | 1.46% | |
| 18 | PTCTPTC Therapeutics Inc | 405,152 | $18.9B | 1.40% | |
| 19 | JAZZJazz Pharmaceuticals PLC | 130,268 | $18.6B | 1.38% | |
| 20 | MRKMerck & Co Inc | 190,559 | $15.8B | 1.17% | |
| 21 | MRUSMerus N.V. | 1,311,039 | $15.7B | 1.17% | |
| 22 | ITCIEURIntra-Cellular Therapies Inc | 503,555 | $12.9B | 0.96% | |
| 23 | —Nucana Biomed Ltd | 2,400,000 | $12.4B | 0.92% | |
| 24 | —ObsEva SA | 4,749,623 | $11.8B | 0.87% | |
| 25 | —Athira Pharma, Inc. | 509,168 | $9.4B | 0.70% | |
| 26 | —Marinus Pharmaceuticals Inc | 175,000 | $9.0B | 0.67% | Call |
| 27 | OTICEUROtonomy Inc | 2,111,596 | $8.6B | 0.63% | |
| 28 | —GW Pharmaceuticals PLC | 82,944 | $8.1B | 0.60% | |
| 29 | CHRSCoherus BioSciences | 434,555 | $8.0B | 0.59% | |
| 30 | CYTKCytokinetics Inc | 349,296 | $7.6B | 0.56% | |
| 31 | —Zymeworks Inc | 151,902 | $7.1B | 0.52% | |
| 32 | CYTKCytokinetics Inc | 325,000 | $7.0B | 0.52% | Put |
| 33 | PTGXProtagonist Therapeutics Inc | 357,769 | $7.0B | 0.52% | |
| 34 | KURAKura Oncology Inc | 225,259 | $6.9B | 0.51% | |
| 35 | SUPNSupernus Pharmaceuticals Inc | 330,295 | $6.9B | 0.51% | |
| 36 | TGTXTG Therapeutics Inc | 250,401 | $6.7B | 0.50% | |
| 37 | XLRNAcceleron Pharma Inc | 59,546 | $6.7B | 0.50% | |
| 38 | RETAEURReata Pharmaceuticals Inc | 68,615 | $6.7B | 0.50% | |
| 39 | —MyoKardia Inc | 48,998 | $6.7B | 0.50% | |
| 40 | ARNAEURArena Pharmaceuticals Inc | 88,150 | $6.6B | 0.49% | |
| 41 | OVIDOvid Therapeutics Inc | 1,097,621 | $6.3B | 0.47% | |
| 42 | MIRMMirum Pharmaceuticals Inc | 321,252 | $6.2B | 0.46% | |
| 43 | —Reata Pharmaceuticals Inc | 60,000 | $5.8B | 0.43% | Put |
| 44 | NVCRNovocure Ltd | 50,000 | $5.6B | 0.41% | Call |
| 45 | AMRNAmarin Corp | 1,170,584 | $4.9B | 0.37% | |
| 46 | ACRSAclaris Therapeutics | 1,911,573 | $4.9B | 0.36% | |
| 47 | PBYIPuma Biotechnology Inc | 475,982 | $4.8B | 0.36% | |
| 48 | —Chiasma | 1,047,354 | $4.5B | 0.33% | |
| 49 | CCXIEURChemoCentryx Inc | 81,235 | $4.5B | 0.33% | |
| 50 | KNSAKiniksa Pharmaceuticals, Ltd | 276,628 | $4.2B | 0.31% | |
| 51 | —Applied Genetic Technologies Corp | 825,071 | $4.0B | 0.30% | |
| 52 | MRNAModerna Inc | 50,000 | $3.5B | 0.26% | Call |
| 53 | —TCR2 Therapeutics Inc | 173,028 | $3.5B | 0.26% | |
| 54 | IMTXImmatics NV | 325,527 | $3.5B | 0.26% | |
| 55 | LQDALiquidia Technologies Inc | 679,400 | $3.3B | 0.25% | |
| 56 | BCRXBioCryst Pharmaceuticals Inc | 793,054 | $2.7B | 0.20% | |
| 57 | FIXXEURHomology Medicines Inc | 238,015 | $2.5B | 0.19% | |
| 58 | —Kadmon Holdings Inc | 629,923 | $2.5B | 0.18% | |
| 59 | CGENCompugen Ltd | 146,592 | $2.4B | 0.18% | |
| 60 | —Entasis Therapeutics Holdings Inc. | 1,012,408 | $2.1B | 0.15% | |
| 61 | ACADACADIA Pharmaceuticals Inc | 48,996 | $2.0B | 0.15% | |
| 62 | —Calithera Biosciences Inc | 493,297 | $1.7B | 0.13% | |
| 63 | FATEFate Therapeutics Inc | 41,400 | $1.7B | 0.12% | |
| 64 | RGNXRegenxbio Inc | 59,507 | $1.6B | 0.12% | |
| 65 | —Synlogic Inc. | 574,972 | $1.2B | 0.09% | |
| 66 | YB4PSavara Inc | 375,591 | $409.0M | 0.03% | |
| 67 | PDSBPDS Biotechnology Corporation | 142,635 | $332.0M | 0.02% | |
| 68 | —Kadmon Holdings Inc | 240,091 | $137.0M | 0.01% |